Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 39

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 39
---
 future
growth. NewGenIvf’s historical revenue growth should not be considered indicative of its future performance. Further, in future
periods, its revenue growth could slow or decline for a number of reasons, including risks, challenges and uncertainties that NewGenIvf
has encountered and may continue to encounter that are frequently experienced by companies at an early stage, slowing demand for its
solutions and fertility services in general, changes in utilization trends by its clients, general economic slowdown, an increase in
unemployment, an increase in competition, changes to health care trends and regulations, changes to science relating to the fertility
market, a decrease in the growth of the fertility market, or its failure, for any reason, to continue to take advantage of growth opportunities.
If NewGenIvf’s assumptions regarding these risks and uncertainties and its future revenue growth are incorrect or change, or if
it does not address these risks successfully, its operating and financial results could differ materially from its expectations, and
its business could suffer.

NewGenIvf’s marketing efforts depend significantly on its ability to receive positive references from its existing clients.

NewGenIvf’s marketing efforts depend significantly on its ability to call on its current clients to provide positive references to new, potential clients. Given its limited number of long-term clients, the loss or dissatisfaction of any client could substantially harm its brand and reputation, inhibit the market adoption of its offering and impair its ability to attract new clients and maintain existing clients. Any of these consequences could have an adverse effect on its business, financial condition and results of operations.

As a public reporting company, we are subject to filing deadlines for reports that we file pursuant to the Exchange Act, and our failure to timely file such reports may have material adverse consequences on our business.

In the past, we have not been able to, and may continue to be unable to produce timely financial statements, and file these financial statements as part of a periodic report in a timely manner with the SEC. For example, we failed to timely file with the SEC the requisite Form 20-F for the year ended December 31, 2023. Consequently, we were not compliant with the periodic reporting requirements under the Exchange Act at such time. We cannot guarantee that in the future our reporting will always be timely. Our failure to timely file future periodic reports with the SEC could subject us to enforcement action by the SEC and shareholder lawsuits and could eventually result in the delisting of our Class A Ordinary Shares from Nasdaq, regulatory sanctions from the SEC, and